MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed profit margin
Profit margin (net margin) is net income as a percentage of revenue.
MariMed's profit margin for the twelve months ending Sep 30, 2026 was -9.3%. For fiscal 2025 it was -9.1%, against -7.9% the year before. The highest annual figure on record is 10.0% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9.1% | −1.2 |
| FY2024 | Dec 31, 2024 | -7.9% | +2.9 |
| FY2023 | Dec 31, 2023 | -10.8% | −20.8 |
| FY2022 | Dec 31, 2022 | 10.0% | +4.1 |
| FY2021 | Dec 31, 2021 | 5.9% | +1.7 |
| FY2020 | Dec 31, 2020 | 4.2% | +182.2 |
| FY2019 | Dec 31, 2019 | -178.0% | −63.2 |
| FY2018 | Dec 31, 2018 | -114.8% | −95.1 |
| FY2017 | Dec 31, 2017 | -19.7% | −14.1 |
| FY2016 | Dec 31, 2016 | -5.6% | +139.8 |
| FY2015 | Dec 31, 2015 | -145.4% | +8251.2 |
| FY2014 | Dec 31, 2014 | -8396.6% | +50851.9 |
| FY2013 | Dec 31, 2013 | -59248.6% | +43877.6 |
| FY2012 | Dec 31, 2012 | -103126.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -7.9% | −0.7 |
| Q2 FY2026 | Jun 30, 2026 | -8.6% | −5.0 |
| Q1 FY2026 | Mar 31, 2026 | -9.6% | +5.0 |
| Q4 FY2025 | Dec 31, 2025 | -11.1% | +10.1 |
| Q3 FY2025 | Sep 30, 2025 | -7.2% | −4.8 |
| Q2 FY2025 | Jun 30, 2025 | -3.5% | +0.6 |
| Q1 FY2025 | Mar 31, 2025 | -14.5% | −11.1 |
| Q4 FY2024 | Dec 31, 2024 | -21.2% | +4.9 |
| Q3 FY2024 | Sep 30, 2024 | -2.5% | +8.5 |
| Q2 FY2024 | Jun 30, 2024 | -4.1% | −1.5 |
| Q1 FY2024 | Mar 31, 2024 | -3.4% | −1.5 |
| Q4 FY2023 | Dec 31, 2023 | -26.1% | −39.4 |
| Q3 FY2023 | Sep 30, 2023 | -11.0% | −19.0 |
| Q2 FY2023 | Jun 30, 2023 | -2.6% | −8.1 |
| Q1 FY2023 | Mar 31, 2023 | -1.9% | −15.3 |
| Q4 FY2022 | Dec 31, 2022 | 13.3% | +34.2 |
| Q3 FY2022 | Sep 30, 2022 | 8.0% | −9.1 |
| Q2 FY2022 | Jun 30, 2022 | 5.5% | −14.7 |
| Q1 FY2022 | Mar 31, 2022 | 13.4% | +1.1 |
| Q4 FY2021 | Dec 31, 2021 | -21.0% | −8.3 |
| Q1 FY2021 | Mar 31, 2021 | 17.1% | +49.6 |
| Q4 FY2020 | Dec 31, 2020 | 20.2% | +1530.9 |
| Q3 FY2020 | Sep 30, 2020 | 12.3% | +78.2 |
| Q2 FY2020 | Jun 30, 2020 | -12.6% | −30.9 |
| Q1 FY2020 | Mar 31, 2020 | -32.4% | −31.8 |
| Q4 FY2019 | Dec 31, 2019 | -1510.7% | −1285.5 |
| Q3 FY2019 | Sep 30, 2019 | -65.9% | +37.4 |
| Q2 FY2019 | Jun 30, 2019 | 18.2% | +33.9 |
| Q1 FY2019 | Mar 31, 2019 | -0.7% | +90.3 |
| Q4 FY2018 | Dec 31, 2018 | -225.1% | −141.8 |
| Q3 FY2018 | Sep 30, 2018 | -103.3% | −80.4 |
| Q2 FY2018 | Jun 30, 2018 | -15.7% | −49.5 |
| Q1 FY2018 | Mar 31, 2018 | -91.0% | −88.1 |
| Q4 FY2017 | Dec 31, 2017 | -83.3% | −84.1 |
| Q3 FY2017 | Sep 30, 2017 | -22.9% | −15.9 |
| Q2 FY2017 | Jun 30, 2017 | 33.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -2.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 0.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -7.0% | – |
See a number that looks wrong?